20:17 , Feb 16, 2017 |  BC Week In Review  |  Financial News

Acticor completes venture financing

Acute ischemic stroke company Acticor Biotech S.A.S. (Paris, France) raised €1.5 million ($1.6 million) from CapDecisif in the second close of a venture round on Feb. 7, bringing the total raised to €2.9 million ($3.2...
07:00 , Mar 21, 2016 |  BC Week In Review  |  Financial News

Gecko Biomedical completes venture financing

Gecko Biomedical S.A.S. , Paris, France   Business: Dermatology   Date completed: 2016-03-17   Type: Venture financing   Raised: EUR22.5 million ($25.1 million)   Investors: Sofinnova Partners; Bpifrance ; Omnes Capital; CM-CIC Capital Innovation; CapDecisif...
00:42 , Mar 18, 2016 |  BC Extra  |  Financial News

Gecko closes EUR 22.5M round

Gecko Biomedical S.A.S. (Paris, France) raised EUR 22.5 million ($25.1 million) in a series A2 round led by new investor Sofinnova Partners. Bpifrance also participated, as did existing investors Omnes Capital, CM-CIC Innovation and CapDecisif...
07:00 , Oct 19, 2015 |  BC Week In Review  |  Financial News

Eyevensys completes venture financing

Eyevensys S.A.S. , Paris, France   Business: Ophthalmic   Date completed: 2015-10-09   Type: Venture financing   Raised: EUR7.5 million ($8.5 million)   Investors: Boehringer Ingelheim Venture Fund; Bpifrance ; CapDecisif; Inserm Transfert  ...
07:00 , Jul 13, 2015 |  BC Week In Review  |  Financial News

InnaVirVax completes venture financing

InnaVirVax S.A. , Evry, France   Business: Infectious, Cancer   Date completed: 2015-07-09   Type: Venture financing   Raised: EUR3.6 million ($4 million)   Investors: CapDecisif; G1J; Pradeyrol Developpement; Fa Diese; Fonds Regional de Co-Investissement...
07:00 , May 25, 2015 |  BioCentury  |  Finance

Cash cravings

BioCentury's 13th annual European Iceberg survey foresees record financing demand, driven on the public side by higher burn rates and the number of companies joining the group via IPOs, and on the private side by...
07:00 , May 26, 2014 |  BioCentury  |  Finance

Europe's Iceberg 2014: Divergent appetites

BioCentury's 12th annual European Iceberg survey projects one of the lowest financing demand figures ever for public biotechs, thanks to the robust funding environment over the last two years. But while private companies actually raised...
08:00 , Dec 16, 2013 |  BC Week In Review  |  Financial News

Gecko Biomedical completes venture financing

Gecko Biomedical S.A.S. , Paris, France   Business: Dermatology   Date completed: 12/9/13   Type: Venture financing   Raised: €8 million ($11 million)   Investors: Omnes Capital; CM-CIC Capital Innovation; CapDecisif  ...
01:29 , Dec 10, 2013 |  BC Extra  |  Financial News

Gecko closes EUR 8 million in A round

Wound care company Gecko Biomedical S.A.S. (Paris, France) closed EUR 8 million ($11 million) in a series A round co-led by new investors Omnes Capital and CM-CIC Capital Finance. New investor CapDecisif Management also participated....
07:00 , May 27, 2013 |  BioCentury  |  Finance

Demand disequilibrium

BioCentury's 11th annual European Iceberg survey sees funding demand continue to fall for a shrinking number of public clinical-stage biotechs in Europe, while the capital demanded by the growing cadre of venture biotechs continues to...